Benzydamine / Chlorhexidine (Mouthwashes and Sprays)

Mechanism

Pharmacological Class and Group

Topical therapeutics of the oral mucosa. Local topical non-steroidal anti-inflammatory with local anesthetic properties and membrane stabilizer (Bencydamine) and broad-spectrum cationic bisbiguanidic antiseptic (Chlorhexidine).

Mechanism of Action

This topical-oral combination combines sustained bactericidal control with immediate relief of pain and the mucosal inflammatory response:

• Benzydamine: It is an atypical NSAID with a weak basic structure. It does not potently inhibit systemic cyclooxygenase enzymes, but rather acts as follows:
  • Inhibits the local synthesis of proinflammatory cytokines (IL-1, TNF-α) by physically stabilizing the membranes of endothelial cells and neutrophils, preventing their local chemotactic activation.
  • It exerts a direct amide-type local anesthetic effect by blocking voltage-sensitive sodium channels in the nociceptive endings of the oral mucosa.
• Chlorhexidine: Bactericidal cationic antiseptic that adheres strongly to the negatively charged surface of the bacterial wall:
  • It interacts electrochemically with the phosphates of the bacterial cell membrane, altering its permeability and destroying bacterial osmotic integrity. This causes the release of phosphorus and potassium and the subsequent precipitation of bacterial cytoplasmic proteins (bactericide).
  • It shows the phenomenon of substantivity: it binds strongly to the hydroxyapatite of the tooth enamel and the mucous membranes of the mouth, slowly releasing itself over a period of 8 to 12 hours, which maintains the prolonged antiseptic effect.

Synergistic Mechanism of Action in Mucositis

Benzydamine: Na channel blockade⁺ Rapid local anesthesia Chlorhexidine: Adhesion by Substantivity Prolonged bactericidal effect of 12 hours

This combination is ideal for the management of radio/chemotherapy-induced mucositis in head and neck oncology, where exposed mucosa requires strict control of bacterial superinfection without interfering with physiological cellular repair.

Pharmacokinetics

High Resolution Pharmacokinetics

• Benzydamine: Rapid local absorption through the inflamed oral mucosa. It penetrates deeply into the subepithelial tissues of the mouth. However, systemic plasma absorption levels are insignificant, not causing systemic renal or digestive toxicity.
• Chlorhexidine: It is not measurably absorbed through intact or inflamed oral mucosa. In case of accidental swallowing of therapeutic doses, it is completely eliminated unchanged through the fecal digestive route (90%), without systemic hepatic metabolism or kidney damage.

Indicators and dose

Clinical Indications and Off-Label Uses

• Oral Mucositis and Inflammation of the Oral Cavity: Analgesic management and prophylaxis of opportunistic infections in patients undergoing radiotherapy or oncological chemotherapy.
• Acute pharyngitis and tonsillitis: Symptomatic relief of severe odynophagia as an adjunct to systemic therapy.
• Postoperative Prophylaxis in Oral and Neck Surgery: Prevention of infections and control of bacterial plaque after tonsillectomy, oral biopsies or salivary gland surgeries.
• Recurrent Aphthous Stomatitis: Reduction in the duration and pain of oral thrush.

Dosage and Clinical Adjustment

Mouthwash (Oral Rinse Solution):

• Perform rinses or gargles with 15 mL of the pure solution (not diluted with water) for a period of 30 to 60 continuous seconds.
• Frequency: Every 8 to 12 hours (2 to 3 times a day).
• Duration Limit (Chlorhexidine): It is advisable not to extend the use of the mouthwash for more than 14 consecutive days to prevent discoloration of the enamel and peeling of the mucosa.

Buccopharyngeal Spray:

• Adults: 4 to 8 direct sprays on the inflamed area of the pharynx or mouth every 3-4 hours.
• Children (6 to 12 years): 4 sprays directed on the inflamed area every 4 hours.

Adjustment in Renal or Hepatic Failure: Does not require dose modifications.

Security

Absolute and Relative Contraindications

Absolute Contraindications

• Known hypersensitivity to benzydamine, chlorhexidine or other local NSAIDs.
• Children under 3 years of age, due to the risk of reflex laryngospasm when directly applying sprays or strong solutions.

Relative Contraindications

• History of severe bronchospasm or airway overactivity (preservatives in the solution may trigger subtle asthma attacks if inadvertently inhaled).

Adverse Effects (ADR) and Specific Toxicity

• Frequent (1%-10%): Transient paresthesias in the tongue or oral mucosa after rinsing (sensation of numbness), temporary alteration of the sense of taste (transient dysgeusia due to the bitter taste of chlorhexidine).
• Uncommon (0.1%-1%): Moderate xerostomia, burning sensation or local irritation of the mucosa if the solution contains traces of alcohol.
• Rare (<0.1%): Staining of the teeth and the back of the tongue (with the use of chlorhexidine for more than 10-14 continuous days; chlorhexidine precipitates the chromogens from dietary foods on the enamel, giving a grayish-brown tint, which is reversible by professional dental prophylaxis).

Drug Interactions of Clinical Relevance

• No clinically relevant systemic interactions have been documented due to the lack of blood bioavailability.
• The use of other topical oral antiseptics or enzymatic oral gels should be avoided simultaneously, as they may precipitate or physically inactivate the excipients of benzydamine/chlorhexidine.

Safety in Pregnancy and Breastfeeding

• Pregnancy: Compatible. They are considered very safe therapeutic alternatives due to the null systemic absorption and the null presence of plasma levels of benzydamine or chlorhexidine.
• Breastfeeding: Compatible. It does not represent a risk of adverse effects for the full-term infant.

Clinical

Clinical Application Pearl: Post-Brushing Wash

The anionic surfactants universally present in most toothpastes for daily use (such as sodium lauryl sulfate) interact electrochemically with chlorhexidine, completely inactivating its bactericidal free cationic charges. The patient should be strictly instructed to rinse the mouth with chlorhexidine at least 30 to 60 minutes after regular tooth brushing to maintain the antiseptic benefit and avoid chemical inactivation.